Koesten Hirschmann & Crabtree’s AbbVie ABBV Stock Holding History

Koesten Hirschmann & Crabtree’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-110	Closed	-$25.4K	–	43
2025 Q3	$25.4K	Sell	110 -9	-8%	-$1.83K	0.01%	110
2025 Q2	$22.1K	Buy	119 +69	+138%	+$12.8K	0.01%	113
2025 Q1	$10.4K	Buy	50 +20	+67%	+$3.89K	0.01%	131
2024 Q4	$5.25K	Hold	30	–	–	﹤0.01%	143
2024 Q3	$5.83K	Hold	30	–	–	﹤0.01%	138
2024 Q2	$5.38K	Hold	30	–	–	﹤0.01%	152
2024 Q1	$5.38K	Hold	30	–	–	﹤0.01%	152
2023 Q4	$4.58K	Hold	30	–	–	﹤0.01%	140
2023 Q3	$4.4K	Hold	30	–	–	﹤0.01%	133
2023 Q2	$3.98K	Sell	30 -6	-17%	-$880	﹤0.01%	124
2023 Q1	$5.66K	Buy	36 +6	+20%	+$917	﹤0.01%	129
2022 Q4	$4.77K	Buy	+30	New	+$4.6K	﹤0.01%	120

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Koesten Hirschmann & Crabtree's ABBV Position: Q4 2025 in Review

Koesten Hirschmann & Crabtree sold out of AbbVie (ABBV) in Q4 2025, closing a stake of 110 shares — an estimated $25.4K sold.

Koesten Hirschmann & Crabtree first reported a position in ABBV in Q4 2022 and held it in 12 quarters. The position peaked at $25.4K in Q3 2025. 4,145 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

Koesten Hirschmann & Crabtree reported no remaining AbbVie position as of Q4 2025 after selling out during the quarter.
Koesten Hirschmann & Crabtree sold 110 AbbVie shares in Q4 2025, an estimated $25.4K.
Koesten Hirschmann & Crabtree first reported a position in AbbVie in Q4 2022 and held it in 12 quarters.
Koesten Hirschmann & Crabtree's AbbVie position peaked at $25.4K in Q3 2025.
4,145 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Koesten Hirschmann & Crabtree's 13F filing for Q4 2025, filed 9 Feb 2026.